Uncuffed Endotracheal Tube for Lung Disease

Overseen By Jamie Heisdorffer

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Minnesota

Disqualifiers: Unsafe for moderate sedation, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 1

200 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This is a comparison of uncuffed endotracheal tube (UCETT) vs. no endotracheal tube (ETT) in endobronchial ultrasound-transbronchial needle aspiration (EBUS-TBNA) procedure under moderate sedation in terms of procedure tolerance, duration of the procedure, desaturation, amount of sedation medication usage.

Who Is on the Research Team?

H. Erhan Dincer

Principal Investigator

University of Minnesota

Are You a Good Fit for This Trial?

This trial is for patients scheduled for an EBUS-TBNA procedure, which is a type of lung biopsy. There are no specific exclusion criteria provided, so it appears open to all individuals who are planned to undergo this procedure.

Inclusion Criteria

I am scheduled for an EBUS-TBNA procedure.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Procedure

Participants undergo the EBUS-TBNA procedure with either an uncuffed endotracheal tube or no endotracheal tube under moderate sedation

1 day

1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after the procedure

1-2 weeks

What Are the Treatments Tested in This Trial?

Interventions

• Uncuffed Endotracheal Tube

Trial Overview The study compares using an uncuffed endotracheal tube (UCETT) versus not using any tube during the EBUS-TBNA procedure. It looks at how well patients tolerate the process, its duration, oxygen levels in blood (desaturation), and sedative medication needed.

How Is the Trial Designed?

Group I: uncuffed endotracheal group Experimental Treatment 1 Intervention

Group II: no endotracheal tube group/control Active Control 1 Intervention

Who Is Running the Clinical Trial?

University of Minnesota

Lead Sponsor

Trials

1,459

Recruited

1,623,000+